Tag: DANG

NVIV, CVM, IWEB & Extended Watchlist

InVivo Therapeutics Holdings Corp. NVIV
–
NVIV has traded as low as 4.84 since the first time we talked about it back on Monday, July 15th, and after just five trading days, hit a high of 6.20 this past Monday.

We’re going to have this stock on our longer-term watchlist moving forward, and would like to see the stock maintain support above 5.00. The technologies they have developed have the potential to be game-changers in the field of spinal cord injury treatment.

Earlier this month, InVivo announced it would be teaming up with the New York Mets to create Major League Baseball’s first Spinal Cord Injury Awareness Day on Sunday, September 15th at Citi Field when the New York Mets host the Miami Marlins at 1:10 p.m. ET.

More Info @

www.invivotherapeutics.com

CEL-SCI Corp. CVM

We want to add CVM to our radars this morning. The stock hit its 52-low of .16 just prior to the closing bell yesterday afternoon, and this morning the company had some fresh news hit the wires. We want to watch this one closely, as conditions like these can often lead to significant bottom bounces.

Today’s PR:

CEL-SCI Corporation (NYSE MKT: CVM) announces the publication of the results of influenza studies by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and CEL-SCI in the Journal of Clinical Investigation, a leading journal for discoveries in basic and clinical biomedical research (2013 J Clin Invest. doi: 10.1172/JCI67550 2013, supplemental information at www.jci.org/articles/view/67550). The studies described in the publication show that when CEL-SCI’s investigational J-LEAPS Influenza Virus treatments were used “in vitro” to activate immune cells called dendritic cells (DCs), these activated dendritic cells, when injected into influenza infected mice, arrested the progression of lethal influenza virus infection in these mice. >>> FULL STORY

 

IceWEB, Inc. IWEB

Yesterday morning we stated our hope that IWEB would break through resistance at .0355- it did that and more. After touching an early morning low of .032, the stock went on a 22% intraday run, with shares trading at .039 at their peak.

In addition, the stock closed with strength (.036), above previous resistance at .0355, maintaining more than half of its daily gains on over 5X its 3mo. average volume, which is often a bullish signal.

From the low following our original alert of IWEB at .023, yesterday’s high represents an overall move of 70% Since that time, the cumulative gains attained by IWEB have amounted to more than 115% in possible profits.

BARCHART.COM has also upgraded its opinion of IWEB to a 72% Overall “Buy” Rating.

Extended Watchlist:
VPLM, DANG, RENN, XRX,

AAPL, EVRM, AUY & Extended Watchlist

Apple, Inc. AAPL Options

On Friday we talked about our interest in the $435 and $440 Calls, and the day’s session certainly provided us with significant opportunity. The $435’s were changing hands for as little as 2.34, and went back over 4.00, and the $440’s went for as low as .60 before running to 1.30 in just the first hour of trading. The $435’s then went on to provide us with a couple of bounce opportunities over the remainder of the day.

Evermedia Group, Inc. EVRM

EVRM came off of Friday’s Extended Watchlist to provide us a couple of chances for modest gains. The stock started the day by trading in a range from .0014-.0016, then dipped back to .0012 before closing at .0014.

Yamana Gold Inc. AUY
We are putting AUY on watch this morning as a potential bottom bounce play. The stock is trading around its 52-week lows, thus we want to be on the lookout for a possible reversal.

Unlike a lot of the OTC gold stocks we cover which are usually beginning-stage companies, this NYSE-traded company is engaged in fairly heavy production. They recently reported a 4% year-over-year increase in gold production for the First Quarter, pulling over 248,000 ounces of gold from the earth, yielding revenues of more than a half-billion dollars.

Couple the recent beating taken by gold, and the earnings and revenue (while impressive in and of themselves) failing to meet Wall Street’s expectations, we can see why the stock has fallen. We also want to be there to see the recovery as well, so we will be continuously montiring AUY for the foreseeable future.

Extended Watchlist:
CERP, EXPU, RAD, RSOL, PACT, IQNT, ROSG, DANG,